mirumpharma.comの競合サイトトップ10

travere.com

Learn about IgA nephropathy (IgAN) and find out about this rare kidney disease and its symptoms, diagnosis, treatment and patient resources

livmarli.com

Explore the site map for the LIVMARLI® Patient website. LIVMARLI (maralixibat) oral solution and tablets are a prescription medicine used to treat cholestatic pruritus (itch) in patients who are 3 months of age and older with Alagille syndrome or cholestatic pruritus (itch) in patients who are 12 months of age and older with progressive familial intrahepatic cholestasis (PFIC). LIVMARLI is not for use in PFIC type 2 patients who have a severe defect in the bile salt export pump (BSEP) protein. Most common side effects include: diarrhea, abdominal pain, vomiting, fat-soluble vitamin deficiency, liver test abnormalities, blood in stool, and bone fractures. See full PI on website.

otezlapro.com

Find answers to frequently asked questions about Otezla® (apremilast), like dosing, healthcare insurance coverage, and more, that may help your patients. Please see full Important Safety Information.

vpriv.com

type 1 gaucher disease (gd1) is a rare, genetic condition that typically runs in the families. this website is a source of information for patients, family and friends.

orencia.com

Starting ORENCIA® infusions or injections? Learn what to expect, how to take it, and key considerations for your treatment journey. Please see Indications and Important Safety Information.

aop-health.com

AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care.

erdera.org

The European partnership for rare diseases, uniting more than 170 public and private organisations across 37 countries.

csl-info.com

cslベーリング株式会社の医療関係者向けサイトです。「ログイン」ページを掲載しています。このサイトは、国内の医師等の医療関係者を対象に情報を提供しています。

bimzelxhcp.com

Discover BIMZELX HCP resources, watch the BIMZELX MOA video, and get the latest BIMZELX clinical data from leading dermatology experts.

stelarainfo.com

STELARA® (ustekinumab) Official Consumer Website. See full Prescribing & Safety Information.